Support The Moscow Times!

Russia to Freeze-Dry Coronavirus Vaccine to Avoid Distribution Challenges – Reuters

The Sputnik V vaccine's liquid form must be stored at minus 18 degrees Celsius or below to maintain its stated 92% efficacy. Zuma / TASS

Russia will transition to primarily freeze-dried doses of its coronavirus vaccine by spring as a workaround to the logistical challenges of transporting liquid doses at controlled temperatures, Reuters reported Monday. 

The Sputnik V vaccine's liquid form must be stored at minus 18 degrees Celsius or below to maintain its stated 92% efficacy. Vaccine storage and transport issues have become a concern after U.S. pharmaceutical giant Pfizer and Germany’s BioNTech announced that their vaccine, shown to be 90% effective, can only survive at minus 70 C.

According to Reuters, Russia has been testing a process of “turning liquid Sputnik V into a dry, white mass that can be stored at normal fridge temperatures” of 2 C to 8 C, which is then diluted and injected.

Kirill Dmitriev, head of the Russian Direct Investment Fund (RDIF) that markets Sputnik V, said that trials showed the “same” immune response to freeze-dried vaccines as to liquid forms.

He added that “a large proportion of doses, if not a majority,” will be freeze-dried starting from February.

Russia plans to produce 2 million doses of Sputnik V by the end of 2020, then ramp up production to 6 million doses per month in spring, officials estimate.

Russia has already begun vaccinating a select group of medics and teachers in far-flung regions in parallel with post-registration clinical trials in Moscow. It has also exported Sputnik V to Belarus, Venezuela, India and the United Arab Emirates.

A late-September test of the supply chain to every Russian region showed that special temperature-controlled containers for liquid Sputnik V doses could maintain a consistent temperature of minus 18.5 C for up to four days, Retuers reported.

“You can’t change the temperature by even half a degree, not even for a minute or a second,” Oleg Baykov, the head of the Moscow logistics and courier firm Biocard which tracked the movements, told Reuters.

We’re like the Spetsnaz [rapid deployment forces] of the world of medical distribution,” he was quoted as saying.

… we have a small favor to ask.

As you may have heard, The Moscow Times, an independent news source for over 30 years, has been unjustly branded as a "foreign agent" by the Russian government. This blatant attempt to silence our voice is a direct assault on the integrity of journalism and the values we hold dear.

We, the journalists of The Moscow Times, refuse to be silenced. Our commitment to providing accurate and unbiased reporting on Russia remains unshaken. But we need your help to continue our critical mission.

Your support, no matter how small, makes a world of difference. If you can, please support us monthly starting from just 2. It's quick to set up, and you can be confident that you're making a significant impact every month by supporting open, independent journalism. Thank you.


Read more